1. Home
  2. PRLD vs OWLT Comparison

PRLD vs OWLT Comparison

Compare PRLD & OWLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLD
  • OWLT
  • Stock Information
  • Founded
  • PRLD 2016
  • OWLT 2013
  • Country
  • PRLD United States
  • OWLT United States
  • Employees
  • PRLD N/A
  • OWLT N/A
  • Industry
  • PRLD Medicinal Chemicals and Botanical Products
  • OWLT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PRLD Health Care
  • OWLT Health Care
  • Exchange
  • PRLD Nasdaq
  • OWLT Nasdaq
  • Market Cap
  • PRLD 73.7M
  • OWLT 73.9M
  • IPO Year
  • PRLD 2020
  • OWLT N/A
  • Fundamental
  • Price
  • PRLD $0.87
  • OWLT $5.22
  • Analyst Decision
  • PRLD Strong Buy
  • OWLT
  • Analyst Count
  • PRLD 2
  • OWLT 0
  • Target Price
  • PRLD $4.50
  • OWLT N/A
  • AVG Volume (30 Days)
  • PRLD 200.4K
  • OWLT 28.9K
  • Earning Date
  • PRLD 03-04-2025
  • OWLT 03-04-2025
  • Dividend Yield
  • PRLD N/A
  • OWLT N/A
  • EPS Growth
  • PRLD N/A
  • OWLT N/A
  • EPS
  • PRLD N/A
  • OWLT N/A
  • Revenue
  • PRLD $3,000,000.00
  • OWLT $78,575,000.00
  • Revenue This Year
  • PRLD N/A
  • OWLT $40.64
  • Revenue Next Year
  • PRLD N/A
  • OWLT $20.09
  • P/E Ratio
  • PRLD N/A
  • OWLT N/A
  • Revenue Growth
  • PRLD N/A
  • OWLT 74.76
  • 52 Week Low
  • PRLD $0.80
  • OWLT $3.20
  • 52 Week High
  • PRLD $6.80
  • OWLT $6.25
  • Technical
  • Relative Strength Index (RSI)
  • PRLD 37.59
  • OWLT 66.91
  • Support Level
  • PRLD $0.87
  • OWLT $4.64
  • Resistance Level
  • PRLD $1.01
  • OWLT $5.00
  • Average True Range (ATR)
  • PRLD 0.08
  • OWLT 0.22
  • MACD
  • PRLD -0.02
  • OWLT 0.05
  • Stochastic Oscillator
  • PRLD 0.90
  • OWLT 89.56

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

About OWLT Owlet Inc.

Owlet Inc is engaged in providing a digital parenting platform that aims to give parents real-time data and insights to help parents feel more calm and confident. Its diversified portfolio of products includes Owlet Smart Sock, the first baby monitor to track an infant's oxygen levels, heart rate, and sleep trends; the Owlet Cam, which turns any smartphone into a baby monitor with high-definition clarity; the Owlet Monitor Duo, which offers the intelligence of the Owlet Smart Sock paired with the Owlet Cam; and Owlet Dream Lab, an interactive online program designed to be a parent's guide to building healthy sleep habits for their infants.

Share on Social Networks: